Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage

Journal of Stroke and Cerebrovascular Diseases

Volumn 21, Issue 1, 2012, Pages 30-41

  Lad, Shivanand P ^a   Hegen, Harald ^a   Gupta, Gaurav ^a   Deisenhammer, Florian ^a   Steinberg, Gary K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cerebral vasospasm; Proteomics; subarachnoid hemorrhage; vasospasm biomarker

Indexed keywords

ADRENOMEDULLIN; ALPHA II SPECTRIN BREAKDOWN PRODUCT; APOLIPOPROTEIN E; BIG ENDOTHELIN 1; BIOLOGICAL MARKER; CHITOTRIOSIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; FIBRINOPEPTIDE A; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROSTANE DERIVATIVE; LACTIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G),N(G) DIMETHYLARGININE; NEUROFILAMENT PROTEIN; NITRATE; NITRIC OXIDE; NITRITE; PLATELET DERIVED GROWTH FACTOR; PROTEIN; PROTEIN S100B; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BRAIN VASOSPASM; CEREBROSPINAL FLUID; HUMAN; MEDLINE; NEUROFILAMENT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; SUBARACHNOID HEMORRHAGE;

BIOLOGICAL MARKERS; HUMANS; NERVE TISSUE PROTEINS; PROTEOMICS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84855506803     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2010.04.004     Document Type: Article

References (45)

1. Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces: Revised recommendations, 2004. Eur J Neurol 2004;11:577-581. (Pubitemid 39279947)
2. Fassbender K, Hodapp B, Rossol S, et al. Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000;31:2971-2975.
3. Kastner S, Oertel MF, Scharbrodt W, et al. Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAH. Acta Neurochir (Wien) 2005;147:1271-1279. (Pubitemid 41674372)
4. Kessler IM, Pacheco YG, Lozzi SP, et al. Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol 2005;64(Suppl 1):S2-S5. (Pubitemid 40828214)
5. Kobayashi H, Ide H, Ishii H, et al. Endothelin-1 levels in plasma and cerebrospinal fluid following subarachnoid hemorrhage. J Clin Neurosci 1995;2:252-256.
6. Seifert V, Loffler BM, Zimmermann M, et al. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 1995;82:55-62.
7. Shirakami G, Magaribuchi T, Shingu K, et al. Changes of endothelin concentration in cerebrospinal fluid and plasma of patients with aneurysmal subarachnoid hemorrhage. Acta Anaesthesiol Scand 1994;38:457-461. (Pubitemid 24204464)
8. Suzuki K, Meguro K, Sakurai T, et al. Endothelin-1 concentration increases in the cerebrospinal fluid in cerebral vasospasm caused by subarachnoid hemorrhage. Surg Neurol 2000;53:131-135. (Pubitemid 30122318)
9. Suzuki R, Masaoka H, Hirata Y, et al. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1992;77:96-100.
10. Ehrenreich H, Lange M, Near KA, et al. Long-term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med (Berl) 1992;192:257-268.
11. Mascia L, Fedorko L, Stewart DJ, et al. Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001;32:1185-1190.
12. Zimmermann M. Endothelin in cerebral vasospasm: Clinical and experimental results. J Neurosurg Sci 1997;41:139-151. (Pubitemid 27459800)
13. Gaetani P, Rodriguez y Baena R, Grignani G, et al. Endothelin and aneurysmal subarachnoid hemorrhage: A study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1994;57:66-72. (Pubitemid 24030910)
14. Gruber A, Roessler K, Georgopoulos A, et al. Evaluation of big endothelin-1 concentrations in serum and ventricular cerebrospinal fluid after early surgical compared with nonsurgical management of ruptured intracranial aneurysms. Neurosurg Focus 2000;8. e6.
15. Mathiesen T, Edner G, Ulfarsson E, et al. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 1997;87:215-220. (Pubitemid 27349105)
16. Gruber A, Rossler K, Graninger W, et al. Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2000;12:297-306.
17. Gaetani P, Tartara F, Pignatti P, et al. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998;20:337-342. (Pubitemid 28247128)
18. Schoch B, Regel JP, Wichert M, et al. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage. Neurosurgery 2007;60:828-836.
19. Kaynar MY, Tanriverdi T, Kafadar AM, et al. Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. J Neurosurg 2004;101:1030-1036. (Pubitemid 43186457)
20. Polin RS, Bavbek M, Shaffrey ME, et al. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 1998;89:559-567. (Pubitemid 28440924)
21. Rothoerl RD, Schebesch KM, Kubitza M, et al. ICAM-1 and VCAM-1 expression following aneurysmal subarachnoid hemorrhage and their possible role in the pathophysiology of subsequent ischemic deficits. Cerebrovasc Dis 2006;22:143-149. (Pubitemid 44114456)
22. Tanriverdi T, Sanus GZ, Ulu MO, et al. Serum and cerebrospinal fluid concentrations of E-selectin in patients with aneurysmal subarachnoid hemorrhage. Braz J Med Biol Res 2005;38:1703-1710. (Pubitemid 41671759)
23. Nylen K, Csajbok LZ, Ost M, et al. CSF-neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage. Neurosci Lett 2006;404:132-136. (Pubitemid 44041783)
24. Petzold A, Keir G, Kay A, et al. Axonal damage and outcome in subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry 2006;77:753-759. (Pubitemid 43837203)
25. Petzold A, Rejdak K, Belli A, et al. Axonal pathology in subarachnoid and intracerebral hemorrhage. J Neurotrauma 2005;22:407-414. (Pubitemid 40434688)
26. Jung CS, Oldfield EH, Harvey-White J, et al. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 2007;107:945-950. (Pubitemid 350255207)
27. Rejdak K, Petzold A, Sharpe MA, et al. Cerebrospinal fluid nitrite/nitrate correlated with oxyhemoglobin and outcome in patients with subarachnoid hemorrhage. J Neurol Sci 2004;219:71-76. (Pubitemid 38406000)
28. Lin CL, Hsu YT, Lin TK, et al. Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med 2006;40:1466-1473.
29. Mori K, Nakajima K, Maeda M. Long-term monitoring of CSF lactate levels and lactate/pyruvate ratios following subarachnoid hemorrhage. Acta Neurochir (Wien) 1993;125:20-26. (Pubitemid 24004057)
30. Lewis SB, Velat GJ, Miralia L, et al. Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: A novel biomarker of proteolytic injury. J Neurosurg 2007;107:792-796. (Pubitemid 47547744)
31. Kay A, Petzold A, Kerr M, et al. Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: Correlation with injury severity and clinical outcome. Stroke 2003;34:637-642. (Pubitemid 36307384)
32. Kim GH, Kellner CP, Hahn DK, et al. Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2008;109:38-43.
33. Borel CO, McKee A, Parra A, et al. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke 2003;34:427-433.
34. Gaetani P, Tancioni F, Grignani G, et al. Platelet-derived growth factor and subarachnoid hemorrhage: A study on cisternal cerebrospinal fluid. Acta Neurochir (Wien) 1997;139:319-324. (Pubitemid 27192412)
35. Kacira T, Hanimoglu H, Kucur M, et al. Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Clin Neurosci 2008;15:1011-1016.
36. Kaynar MY, Tanriverdi T, Kafadar AM, et al. YKL-40 levels in the cerebrospinal fluid and serum of patients with aneurismal subarachnoid hemorrhage: Preliminary results. J Clin Neurosci 2005;12:754-757. (Pubitemid 41411879)
37. Isman FK, Kacira T, Kucur M, et al. Cerebrospinal fluid and serum chitotriosidase levels in patients with aneurysmal subarachnoid hemorrhage: Preliminary results. Turk Neurosurg 2007;17:235-242.
38. Fujioka M, Nishio K, Sakaki T, et al. Adrenomedullin in patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000;31:3079-3083.
39. Hirashima Y, Nakamura S, Suzuki M, et al. Cerebrospinal fluid tissue factor and thrombin - antithrombin III complex as indicators of tissue injury after subarachnoid hemorrhage. Stroke 1997;28:1666-1670. (Pubitemid 27391431)
40. Kasuya H, Shimizu T, Takakura K. Thrombin activity in CSF after SAH is correlated with the degree of SAH the persistence of subarachnoid clot and the development of vasospasm. Acta Neurochir (Wien) 1998;140:579-584. (Pubitemid 28345060)
41. Keyrouz SG, Diringer MN. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 2007;11:220.
42. Piednoir P, Geeraerts T, Leblanc PE, et al. Early diagnostic for vasospasm after aneurysmal subarachnoid hemorrhage. Ann Fr Anesth Reanim 2007;26:965-972 (in French). (Pubitemid 350137660)
43. Kolias AG, Sen J, Belli A. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: Putative mechanisms and novel approaches. J Neurosci Res 2009;87:1-11.
44. Simard JM, Geng Z, Woo SK, et al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2009;29:317-330.
45. Zemke D, Farooq MU, Mohammed Yahia A, et al. Delayed ischemia after subarachnoid hemorrhage: Result of vasospasm alone or a broader vasculopathy? Vasc Med 2007;12:243-249. (Pubitemid 350055160)